Rochester, NY 9/2/2009 7:42:06 AM
IsoRay, Inc., ISR, Down 8.73% in Tuesday session
IsoRay, Inc.
IsoRay, Inc. utilizing its radioisotope technology to produce a therapeutic medical isotope with a goal of providing improved patient outcomes in the treatment of prostate cancer and other malignant disease, hit a market low hitting 0.11 cents down during Tuesday trading.
In December 2007, IsoRay began selling its Proxcelan Cs-131 seeds for the treatment of ocular melanoma. Cs-131 could also be applied as a treatment for other solid tumor applications such as breast, lung, liver, brain and pancreatic cancer, expanding the total available market opportunity for Cs-131 brachytherapy.
Whisperfromwallstreet.com is a FREE award winning newsletter dedicated to uncovering stocks that are about to move. Please click here to join now.
Last Trade: 1.18
Day's Range: 1.11 - 1.46
52wk Range: 0.12 - 2.06
Change: Down Down 0.1126 (8.73%)
Volume: 405,043
Avg Vol (3m): 738,482
ABOUT IsoRay, Inc.
IsoRay, Inc. engages in the development, manufacture, and sale of isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. It primarily produces Proxcelan Cesium-131 brachytherapy seed for the treatment of prostate cancer and other solid tumor applications, such as breast, lung, liver, brain, and pancreatic cancer. Brachytherapy seeds are small devices used in an internal radiation therapy procedure. The company is headquartered in Richland, Washington.
ABOUT WhisperFromWallStreet.com
WhisperFromWallStreet.com offers free daily stock alerts on companies ready to run. Scroll to the bottom of this page to signup for free stock alerts and visit our site.
WhisperFromWallStreet.com has a dedicated team uncovering stocks ready to break and run. We apply time tested criteria and when one of these stocks meets or exceeds our benchmarks, our subscribers are immediately notified directly to their in-box.
This is a free service available only to our subscribers. Scroll to the bottom of this page to signup for free stock alerts and visit our site.
During 2009 our alerts have resulted in an average price gain of 80%+.
Disclaimer: Full disclaimer at http://WhisperFromWallStreet.com/disclaimer.php
IMPORTANT: Never invest in any stock featured in any press release, email or website unless you can afford the loss of your entire investment. Stocks and particularly penny stocks have the possibility for dramatic gains, and also losses. Neither StockEinstein, nor any of its affiliates are registered investment advisors or broker dealers.
